dangers of compunded semaglutide FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products FDA Warns Against Using Compounded

For a 10% or more weight loss, the figures were 25.2% in the liraglutide group compared to 6.7% in the placebo group

You can wash your face gently

EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets

The FDA cited the telehealth company for making statements on its website that were false or misleading, including claims that its products were weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy and contained clinically proven ingredients. In the warning letter, dated September 9, the agency emphasized that compounded drug products are not FDA-approved, and Hims & Hers statements implied equivalency to FDA-approved medications, which is not accurate

Handling: Always attach a new needle before each injection and remove it after the injection to avoid contamination and ensure a sterile needle for each dose